Bureau of Medicine and Surgery

The Department of the Navy Bureau of Medicine and Surgery, a sub-agency within the Department of Defense responsible for procuring medical supplies, equipment, pharmaceuticals, and clinical services to support Navy and Marine Corps personnel and facilities, is primarily a contract-driven organization with minimal grant activity.

The Bureau's contract footprint is massive: 230,265 awards across a $52.7 billion combined potential value, with $45.22 billion obligated. Activity has contracted sharply over recent years—3,494 awards in 2022, 2,895 in 2023, 2,412 in 2024, 1,804 in 2025, and 722 year-to-date in 2026. The portfolio spans 18,074 distinct prime contractors, reflecting a highly fragmented competitive landscape. Over the last five years, the top five primes by award count—Arocep Federal LLC (534 awards), Caprice Electronics Inc. (308 awards), Seva Technical Services Inc. (279 awards), Document Imaging Dimensions Inc. (261 awards), and miscellaneous foreign awardees (231 awards)—account for just 14 percent of recent awards. When ranked by potential value, the picture diverges sharply: Professional Contract Services Inc. leads with $184.1 million combined potential value across 109 awards, followed by Siemens Healthcare Diagnostics Inc. ($13.1 million, 143 awards) and Microgenics Corporation ($3.6 million, 188 awards). The by-value top five hold 0 percent of combined potential value from the full five-year window, indicating that reported value concentrates elsewhere or that many awards fall below reporting thresholds. Recent awards show substantial volume with no reported potential value—a structural signal that the Bureau transacts heavily through Schedule task orders, BPA calls, modifications, or below-threshold purchase orders.

Set-asides are minimal: 88 percent of awards carry no set-aside designation, small-business set-asides account for 9 percent, and remaining designations (8(a), SDVOSB, HUBZone, WOSB) together represent 2 percent or less. The Bureau issued its most recent contract award on October 1, 2026.

Grant activity is negligible: 16 awards total across $201.1 million obligated, split evenly between Project Grants (9 awards, 56 percent) and Cooperative Agreements (7 awards, 44 percent). Only 8 distinct recipients are on record, with the most recent grant award closing in January 2020. Grant award cadence has slowed to near-zero; no grant opportunities are currently recorded.